Bryant J - Search Results

1

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.

Fisher B, Dignam J, Bryant J, Wolmark N. Fisher B, et al. Among authors: bryant j. J Natl Cancer Inst. 2001 May 2;93(9):684-90. doi: 10.1093/jnci/93.9.684. J Natl Cancer Inst. 2001. PMID: 11333290 Clinical Trial.

2

Preparation of viable tumour cell vaccine from human solid tumours: relationship between tumour mass and cell yield. The Tissue Bank, Pittsburgh Cancer Institute.

Logan TF, Shannon W, Bryant J, Kane P, Wolmark N, Posner M, Kirkwood JM, Ernstoff MS, Futrell JW, Straw LD, et al. Logan TF, et al. Among authors: bryant j. Melanoma Res. 1993 Dec;3(6):451-5. doi: 10.1097/00008390-199311000-00008. Melanoma Res. 1993. PMID: 8161884

3

Breast cancer trials on trial: a case of conflicting ethical interests.

Anderson SJ, Costantino JP, Brown AM, Bryant JL, Cronin WM, Dignam JJ, Jones JM, Rockette HE, Wieand S. Anderson SJ, et al. Among authors: bryant jl. Cancer. 1995 Oct 1;76(7):1294-5. doi: 10.1002/1097-0142(19951001)76:7<1294::aid-cncr2820760729>3.0.co;2-u. Cancer. 1995. PMID: 8630911 No abstract available.

4

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.

Fisher B, Dignam J, Bryant J, DeCillis A, Wickerham DL, Wolmark N, Costantino J, Redmond C, Fisher ER, Bowman DM, Deschênes L, Dimitrov NV, Margolese RG, Robidoux A, Shibata H, Terz J, Paterson AH, Feldman MI, Farrar W, Evans J, Lickley HL. Fisher B, et al. Among authors: bryant j. J Natl Cancer Inst. 1996 Nov 6;88(21):1529-42. doi: 10.1093/jnci/88.21.1529. J Natl Cancer Inst. 1996. PMID: 8901851 Clinical Trial.

5

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.

Fisher B, Dignam J, Wolmark N, DeCillis A, Emir B, Wickerham DL, Bryant J, Dimitrov NV, Abramson N, Atkins JN, Shibata H, Deschenes L, Margolese RG. Fisher B, et al. Among authors: bryant j. J Natl Cancer Inst. 1997 Nov 19;89(22):1673-82. doi: 10.1093/jnci/89.22.1673. J Natl Cancer Inst. 1997. PMID: 9390536 Clinical Trial.

6

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB Jr, Hoehn JL, Lees AW, Dimitrov NV, Bear HD. Fisher B, et al. Among authors: bryant j. J Clin Oncol. 1998 Aug;16(8):2672-85. doi: 10.1200/JCO.1998.16.8.2672. J Clin Oncol. 1998. PMID: 9704717 Corrected and republished. Clinical Trial.

7

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer.

Paik S, Bryant J, Park C, Fisher B, Tan-Chiu E, Hyams D, Fisher ER, Lippman ME, Wickerham DL, Wolmark N. Paik S, et al. Among authors: bryant j. J Natl Cancer Inst. 1998 Sep 16;90(18):1361-70. doi: 10.1093/jnci/90.18.1361. J Natl Cancer Inst. 1998. PMID: 9747867

8

Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

Wolmark N, Bryant J, Smith R, Grem J, Allegra C, Hyams D, Atkins J, Dimitrov N, Oishi R, Prager D, Fehrenbacher L, Romond E, Colangelo L, Fisher B. Wolmark N, et al. Among authors: bryant j. J Natl Cancer Inst. 1998 Dec 2;90(23):1810-6. doi: 10.1093/jnci/90.23.1810. J Natl Cancer Inst. 1998. PMID: 9839521 Clinical Trial.

9

Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project.

Dignam JJ, Bryant J, Wieand HS, Fisher B, Wolmark N. Dignam JJ, et al. Among authors: bryant j. Control Clin Trials. 1998 Dec;19(6):575-88. doi: 10.1016/s0197-2456(98)00041-5. Control Clin Trials. 1998. PMID: 9875837 Clinical Trial.

10

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer.

Bryant J, Fisher B, Gündüz N, Costantino JP, Emir B. Bryant J, et al. Breast Cancer Res Treat. 1998;51(3):239-53. doi: 10.1023/a:1006184428857. Breast Cancer Res Treat. 1998. PMID: 10068082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,802 results

Search Page